Treatment-Resistant Depression: What is the role of Ketamine, DBS, VNS, TMS, and Psychedelics? Special Guest Dr. Scott Aaronson

Join the Editors of The Journal of Psychedelic Psychiatry as they
discuss Treatment-Resistant Depression with Special Guest and
Psychiatrist Dr. Scott Aaronson.


Dr. Scott Aaronson obtained his M.D. from Harvard University in
1981. He is currently an Associate Professor at The University of
Maryland School of Medicine, a Distinguished Life Fellow of the
American Psychiatric Association, a Fellow of The American
College of Psychiatrists. He serves on the board of the American
Society of Clinical Psychopharmacology and the board of the
Clinical TMS Society. He currently is the Director of Clinical
Research for The Retreat at Sheppard Pratt.


Referenced Articles on Treatment-Resistant Depression:


https://www.ncbi.nlm.nih.gov/pubmed/30974339


https://journals.sagepub.com/doi/abs/10.1177/0004867418808585?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=anpa


Follow us:


Website: https://www.journalofpsychedelicpsychiatry.org/


Twitter: https://twitter.com/psychedelic_org


Facebook:
https://www.facebook.com/JournalofPsychedelicPsychiatry/


Instagram:
https://www.instagram.com/journalpsychedelicpsychiatry/